Marina Caputo

ORCID: 0000-0003-0470-9343
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pituitary Gland Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Diet and metabolism studies
  • Adrenal and Paraganglionic Tumors
  • Thyroid Cancer Diagnosis and Treatment
  • Diabetes Treatment and Management
  • Neuroblastoma Research and Treatments
  • Adrenal Hormones and Disorders
  • Hormonal Regulation and Hypertension
  • Obesity, Physical Activity, Diet
  • Metabolism, Diabetes, and Cancer
  • Cancer, Hypoxia, and Metabolism
  • Nutrition, Genetics, and Disease
  • Thyroid Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Nutritional Studies and Diet
  • Genetic Syndromes and Imprinting
  • Nuclear Structure and Function
  • Traumatic Brain Injury Research
  • Lipoproteins and Cardiovascular Health
  • Bariatric Surgery and Outcomes
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Gut microbiota and health
  • Cancer, Lipids, and Metabolism
  • Pancreatic function and diabetes

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2015-2025

Marywood University
2024

Department of Medical Sciences
2024

Northwestern University
2024

Azienda Ospedaliero Universitaria Maggiore della Carita
2020-2022

Ospedale Maggiore
2022

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2022

Fondazione IRCCS Istituto Nazionale dei Tumori
2019

Universidade Federal de São Paulo
2019

Fundação de Apoio à Universidade Federal de São Paulo
2018-2019

Variations in gut microbiota might impact metabolism leading to body weight excess. We assessed the of a probiotic supplementation pediatric obesity on weight, metabolic alterations, selected microbial groups, and functionality.Cross-over, double-blind, randomized control trial (BIFI-OBESE trial; NCT03261466). 101 youths (6-18 years, Tanner stage ≥2) with insulin-resistance diet were 2 × 109 CFU/AFU/day Bifidobacterium breve BR03 (DSM 16604) B. B632 24706) (51) or placebo (50) for 8 weeks...

10.1016/j.clnu.2021.06.002 article EN cc-by-nc-nd Clinical Nutrition 2021-06-11

The Oxford Cognitive Screen (OCS) was recently developed with the aim of describing cognitive deficits after stroke. scale consists 10 tasks encompassing five domains: attention and executive function, language, memory, number processing, praxis. OCS devised to be inclusive un-confounded by aphasia neglect. As such, it may have a greater potential informative on stroke widely used instruments, such as Mini-Mental State Examination (MMSE) or Montreal Assessment, which were originally for...

10.3389/fneur.2018.00101 article EN cc-by Frontiers in Neurology 2018-02-28

Our aim was to evaluate adherence the Mediterranean diet (MedDiet) among children and adolescents with type 1 diabetes (T1D) in relation metabolic control. Adherence MedDiet assessed Diet Quality Index (KIDMED) questionnaire physical activity by International Physical Activity Questionnaire for Adolescent (IPAQ-A) on 65 subjects (32 males, 9-18 years) T1D. Clinical evaluation performed (standardized body mass index (BMI-SDS), hemoglobin A1C (HbA1c), continuous glucose monitoring metrics when...

10.3390/nu14030596 article EN Nutrients 2022-01-29

Objective: To retrospectively evaluate external beam reirradiation (re-EBRT) delivered to the prostate/prostatic bed for local recurrence, after radical or adjuvant/salvage radiotherapy (RT). Methods: 32 patients received re-EBRT between February 2008 and October 2013. All had clinical/radiological relapse in prostate prostatic no distant metastasis. was with selective RT technologies [stereotactic including CyberKnifeTM (Accuray, Sunnyvale, CA); image-guidance intensity-modulated etc.]....

10.1259/bjr.20150197 article EN British Journal of Radiology 2015-06-09

Registered trials and real-world evidence (RWE) studies provided on the efficacy of once-weekly (OW) semaglutide hyperglycaemia cardiovascular risk factors as add-on or de-novo treatment in type 2 diabetes (T2D).In a retrospective analysis electronic data files from 258 T2D patients, this RWE study aimed to explore impact OW biochemical anthropometric outcomes after 6 12 months patients receiving at least one prescription between September 2019 May 2021.During period, 154 56 consecutive...

10.1007/s40618-022-01799-2 article EN cc-by Journal of Endocrinological Investigation 2022-04-16
Mario Luca Morieri Riccardo Candido Simona Frontoni Olga Disoteo Anna Solini and 95 more Gian Paolo Fadini Francesco Bellanti Massimiliano Caprio Michele Cutolo Gloria Formoso Elisa Forte Vera Frison Giovanna Gregori Cristina Lencioni Gaetano Leto S Mandica Alberto Marangoni Pasqualina Memoli G Memoli Carlo Negri Laura Nollino Andrea Perrelli Sebastio Perrini Flavia Prodam Alberto Rebora Daniela Sansone Marcello Sciaraffia Silvio Settembrini G Sodo F. Tassone Valentina Todisco Antonio Vetrano Giacomo Accardo Valeria Albanese Irene Alemanno Stefano Allasia Rosario Alosa Anna Altomari Anna Maria Letizia Amato E. Ambrosetti Angela Angarano Stefania Angotti Roberto Anichini Fabio Baccetti M. Balbo E Balestra Sara Balzano Maria Vittoria Barone Walter Baronti Veronica Basso Guglielmo Beccuti Iaele Maria Bellone Alessandra Bertolotto Michela Bettio Cristina Bittante Nadia Bonelli Marzia Bongiovanni Benedetta Maria Bonora Barbara Bonsembiante Laura Borgognoni Daniela Bracaglia Antonia Francesca Braione Clementina Brancario Sabrina Braucci L. Briatore Elisabetta Brun Valeria Cambria Elena Cantino Paolo Capitanata Sergio Cappello Marina Caputo Barbara Carabba Alberto Carpenito Marco Castellana Anna Castrovilli Donato Cataldo Giuliana Cazzetta Francesca Cecoli Nino Cristiano Chilelli Marco Cianciullo Federica Coccia Sara Colarusso C Colella Isabella Colletti Sara Coluzzi Marisa Conte Marco Corigliano Alessandra Cosma Silvana Costa Pantaleo Daniele Maria D’aurizio Alessandra De Bellis Lorenzo De Candia Giovanni Gennaro E De Luca Claudia De Natale Giuseppina Simone Raffaele De Simone Andrea Del Buono Vincenza Delmonte

This study aimed to address therapeutic inertia in the management of type 2 diabetes (T2D) by investigating potential early treatment with oral semaglutide. A cross-sectional survey was conducted between October 2021 and April 2022 among specialists treating individuals T2D. scientific committee designed a data collection form covering demographics, cardiovascular risk, glucose control metrics, ongoing therapies, physician judgments on appropriateness. Participants completed anonymous...

10.1007/s13300-023-01490-6 article EN cc-by-nc Diabetes Therapy 2023-10-18
Coming Soon ...